Safety Study of SEA-CD40 in Cancer Patients

Clinical trial NCT02376699 · TERMINATED

Trial details

NCT number: NCT02376699
Sponsor: Seagen Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Hodgkin Disease Lymphoma Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Melanoma Neoplasm Metastasis Neoplasms, Head and Neck Neoplasms, Squamous Cell Non-Small Cell Lung Cancer

Start date: 2015-02-28
Primary completion: 2023-03-06
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.